Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Genomics02:02

Genomics

36.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.4K
Proteomics01:33

Proteomics

7.4K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Methodological considerations for evaluating deep learning segmentation models in digital pathology whole-slide images.

Journal of medical imaging (Bellingham, Wash.)·2026
Same author

Data Representativeness with Hyperdimensional Computing.

Journal of imaging informatics in medicine·2026
Same author

FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Integrated computational and experimental immunoengineering of adeno-associated virus capsid T cell epitopes in mice.

Nature communications·2026
Same author

Leveraging Artificial Intelligence in Drug and Biological Product Development: An FDA and Clinical Trial Transformation Initiative Workshop Report.

NEJM AI·2025
Same author

Mitigating Limited Data Challenges to Improve Artificial Intelligence Integration in Rare Disease Drug Development.

NEJM AI·2025
Same journal

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

Clinical pharmacology and therapeutics·2026
Same journal

Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

Clinical pharmacology and therapeutics·2026
Same journal

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

Clinical pharmacology and therapeutics·2026
Same journal

Reply to: "The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient".

Clinical pharmacology and therapeutics·2026
Same journal

Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

Clinical pharmacology and therapeutics·2026
Same journal

Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused Registries.

Clinical pharmacology and therapeutics·2026
查看所有相关文章

相关实验视频

Updated: Jul 11, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.3K

良好的机器学习的方法与多omics数据的方法.

Thibaud Coroller1, Berkman Sahiner2, Anup Amatya3

  • 1Novartis Pharmaceutical Company, East Hanover, New Jersey, USA.

Clinical pharmacology and therapeutics
|November 15, 2023
PubMed
概括
此摘要是机器生成的。

诺华和FDA在为期四年的项目中合作,使用先进的分析方法发现了转移性乳腺癌的新放射基因组因素. 这项研究为未来的整合人工智能和机器学习的多学科项目提供了指导方针.

更多相关视频

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

3.7K

相关实验视频

Last Updated: Jul 11, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

3.7K

科学领域:

  • 在瘤学瘤学.
  • 放射学 放射学是一门学科.
  • 基因组学就是基因组学.
  • 数据科学数据科学数据科学

背景情况:

  • 诺华制药公司与美国食品和药物管理局 (FDA) 之间的为期四年的合作于2020年开始.
  • 该项目侧重于新的数据模式和先进的分析.
  • 主要的科学问题是确定HR+/HER-转移性乳腺癌的预后和预测因素.

研究的目的:

  • 为涉及跨机构的多学科团队的多主题项目提供切实可见的指导方针.
  • 分享通过利用人工智能 (AI) 和机器学习 (ML) 的合作项目获得的见解.
  • 为实施探索性数据科学项目提供可操作的指导.

主要方法:

  • 探索基于放射基因组学的新预后和预测因素.
  • 应用高级分析,包括人工智能和机器学习.
  • 通过四个关键步骤对多主题项目的结构化方法:计划,设计,开发和传播.

主要成果:

  • 已经产生了有价值的见解,以促进未来的科学项目.
  • 展示了整合复杂数据模式和高级分析的潜力.
  • 提供了有效沟通的实际策略和协作研究中的良好数据科学实践.

结论:

  • 这次合作为转移性乳腺癌的放射基因组学提供了重要的见解.
  • 制定的指导方针为成功的多学科研究努力提供了一个框架.
  • 有效的沟通和强大的数据科学实践对于机构间的科学项目至关重要.